Skip to main content
FF
NYSE Industrial Applications And Services

FutureFuel Posts $8.4M Q3 Loss on Record $104.7M Revenue; Q4 Adjusted EBITDA Guided to ~$7M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$4.61
Mkt Cap
$222.387M
52W Low
$3.09
52W High
$6.99
52W Position info
49% above low
Off High info
34% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

FF sits 49% above its 52-week low of $3.09.

Summary

FutureFuel posted a $8.4 million Q3 loss on $104.7 million of revenue, driven by biodiesel growth offset by feedstock and derivative losses, and guided Q4 Adjusted EBITDA to about $7 million for a positive full year.


Key Events · Earnings and Guidance · FF

  • Q3 Revenue Quadruples to $104.7M

    Total revenue rose 361.3% to $104.7 million from $22.7 million, with $45.7 million from pricing and $36.3 million from volume and mix, principally in Biofuels.

  • Net Loss of $8.4M, Adjusted EBITDA -$4.9M

    GAAP net loss was ($8.4) million, or ($0.19) per diluted share, and Adjusted EBITDA was a ($4.9) million loss, including $8.7 million of net derivative losses.

  • Q4 Adjusted EBITDA Guided to ~$7M

    Management expects approximately $7 million of Q4 Adjusted EBITDA and positive full-year 2026 Adjusted EBITDA, with more than 90% of Q4 biodiesel capacity already booked.

  • Cash Falls to $21.3M

    Cash and equivalents dropped to $21.3 million at September 30, 2026 from $34.3 million at June 30, 2026, against a $35 million revolver with no outstanding borrowings.


Analysis · FF · Industrial Applications And Services

Revenue quadrupled to $104.7 million as biodiesel volumes and pricing surged, yet the quarter still produced an $8.4 million net loss and negative $4.9 million Adjusted EBITDA, with feedstock costs and $8.7 million of derivative losses swamping the top line. What matters is the forward picture: management expects roughly $7 million of Q4 Adjusted EBITDA, which would make full-year 2026 positive, and says more than 90% of Q4 biodiesel capacity is already booked. Cash fell to $21.3 million from $34.3 million in the prior quarter, so the $35 million undrawn revolver and the promised Q4 recovery carry the liquidity story into year-end.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FF was trading at $4.61 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $222.4M. The 52-week trading range was $3.09 to $6.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FF - Latest Insights

FF
Aug 10, 2026, 4:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $4.65 info
Change: -$1.60 (-26%) info
Market Cap: $222.387M info
FF
Aug 10, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.16
Real-time Price: $4.65 info
Change: -$0.510 (-10%) info
Market Cap: $222.387M info
FF
May 11, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.54
Real-time Price: $4.65 info
Change: +$0.110 (+2%) info
Market Cap: $222.387M info
FF
May 11, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.54
Real-time Price: $4.65 info
Change: +$0.110 (+2%) info
Market Cap: $222.387M info
FF
Mar 31, 2026, 8:33 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.92
Real-time Price: $4.65 info
Change: +$0.730 (+19%) info
Market Cap: $222.387M info